Company Profile

XN Biotechnologies LLC
Profile last edited on: 3/22/2022      CAGE: 8PPF2      UEI: GL1MD7F116L6

Business Identifier: Improving diagnostics in kidney disease patients
Year Founded
2019
First Award
2021
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

6734A Marquette Avenue
St. Louis, MO 63139
   (806) 407-2554
   N/A
   N/A
Location: Single
Congr. District: 01
County: St. Louis city

Public Profile

In collaboration with personnel at Washington University in St Louis, MO, XN Biotechnologies, LLC is tackling development of improved diagnostics in patients with kidney disease. The effort is to yield a three-dimensional map of kidney microstructure and function, based on radiological imaging. Used to guide early interventions potentially to prevent chronic kidney disease, the firm is also associated with development of an image processing software package that could be bing used as a diagnostic device accurately to detect and grade tumors in the prostate. This imaging tool could lead ultimately lead to elimination of unnecessary biopsies, overtreatment and associated complications.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 1 NIH $299,633
Project Title: Translational imaging tools to nondestructively measure nephron mass

Key People / Management

  Edwin Baldelomar

  Edwin J Baldelomar

  Kevin M Bennett

Company News

There are no news available.